Pancreatic Neuroendocrine Tumor (NETs) Diagnostic Testing

Pancreatic Neuroendocrine Tumor (NETs) Diagnostic Testing

Providing continuity of service for rare Endocrinology and Gastroenterology testing since 1969
is still the hallmark of Inter Science Institute.

Read more about these conclusions about ISI’s Pancreastatin assay providing valuable information for patients at high risk of recurrence and accurately detecting progression.

Luncheon With The Experts

On November 19th, Inter Science Institute’s C.O.O., Mia S. Tepper, MBA was the featured speaker on the Carcinoid Cancer Foundation “Luncheon with the Experts”.

Click this link to view the video. 

The Carcinoid Cancer Foundation began as the Carcinoid Tumor and Serotonin Research Foundation in 1968 when the NIH fund for rare cancers was terminated. The name was changed to the Carcinoid Cancer Foundation in 1995. It is a nonprofit organization chartered by the State of New York for the purpose of encouraging and supporting education and research on carcinoid and related neuroendocrine cancers. For more information go to: www.carcinoid.org.

5-HIAA assay is now available on plasma (Z-tubeTM) from ISI

New test available for patients: the 5-HIAA assay is now available on plasma (Z-tubeTM) from ISI. Click here to see the requirements.

Just added: two new peer-reviewed published papers on Pancreastatin

C.U.R.E.® Catalogue

The C.U.R.E.® Catalogue lists over 150 individual assays, that can be performed on plasma/serum, urine, CSF, Saliva, and other fluids in the areas of:

  • G.I. & Pancreatic Tests
  • Hypertension, Corticosteroid, & Mineralocorticoid Tests
  • Hypothalamic-pituitary Axis & Releasing Factor Tests
  • Multi-disciplinary Tests
    Pediatric & Enzyme Deficiency Tests
  • Reproductive Endocrinology & Gonadal
  • Steroid Tests
  • Thyroid Tests

Please contact ISI for the most up-to-date testing availability.

Search Individual Assays

For the Most Recent Edition of the C.U.R.E.® (Current Unique and Rare Endocrine) Catalogue please contact the Institute at: requests@interscienceinstitute.com

ISI is the leader in neuroendocrine tumors (NET's) Biomarker Testing

Updated with ICD-10 codes

Since 1969, our cutting-edge esoteric services to the medical, research, and academic communities, Inter Science Institute specializes in research and development emphasis in the area of Neuroendocrine Tumors (NET’s). The current 5th edition handbook, Neuroendocrine Tumors: A Comprehensive Guide to Diagnosis and Management, is available for download on this website or by contacting ISI at requests@interscienceinstitute.com.

Click here for the previous edition.